Literature DB >> 23215460

Prostratin and 12-O-tetradecanoylphorbol 13-acetate are potent and selective inhibitors of Chikungunya virus replication.

Mélanie Bourjot1, Leen Delang, Van Hung Nguyen, Johan Neyts, Françoise Guéritte, Pieter Leyssen, Marc Litaudon.   

Abstract

A chemical study of the Vietnamese plant species Trigonostemon howii led to the isolation of a new tigliane-type diterpenoid, trigowiin A (1), along with several known coumarins and phenylpropanoids. The planar structure and the relative configuration of compound 1 were elucidated based on spectroscopic analysis, including 1D- and 2D-NMR experiments, mass spectrometry, and comparison with literature data. Trigowiin A (1) exhibited moderate antiviral activity in a virus-cell-based assay for Chikungunya virus (CHIKV). Since the structure of compound 1 is closely related to those of well-known tigliane diterpenoids such as prostratin (2), phorbol (3), 12-O-tetradecanoylphorbol 13-acetate (TPA) (4), and 4α-TPA (5), the antiviral activity of the latter compounds was also evaluated against CHIKV, as well as in virus-cell-based assays of two additional members of the genus Alphavirus (Sindbis virus, SINV, and Semliki forest virus, SFV). Whereas prostratin inhibited CHIKV replication with a moderate EC(50) of 2.6 μM and a selectivity index (SI) approximating 30, compound 4 proved to be an extremely potent inhibitor, with an EC(50) of ∼3 nM and a SI near 2000. Interestingly, no or very little activity was observed on the replication of SINV and SFV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23215460     DOI: 10.1021/np300637t

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  18 in total

1.  Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.

Authors:  Daryl Staveness; Rana Abdelnabi; Katherine E Near; Yu Nakagawa; Johan Neyts; Leen Delang; Pieter Leyssen; Paul A Wender
Journal:  J Nat Prod       Date:  2016-02-22       Impact factor: 4.050

Review 2.  Towards antivirals against chikungunya virus.

Authors:  Rana Abdelnabi; Johan Neyts; Leen Delang
Journal:  Antiviral Res       Date:  2015-06-25       Impact factor: 5.970

3.  Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism.

Authors:  Rana Abdelnabi; Daryl Staveness; Katherine E Near; Paul A Wender; Leen Delang; Johan Neyts; Pieter Leyssen
Journal:  Biochem Pharmacol       Date:  2016-09-21       Impact factor: 5.858

Review 4.  Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective.

Authors:  Soumendranath Bhakat; Mahmoud E S Soliman
Journal:  J Nat Med       Date:  2015-04-29       Impact factor: 2.343

5.  Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death.

Authors:  Daryl Staveness; Rana Abdelnabi; Adam J Schrier; Brian A Loy; Vishal A Verma; Brian A DeChristopher; Katherine E Near; Johan Neyts; Leen Delang; Pieter Leyssen; Paul A Wender
Journal:  J Nat Prod       Date:  2016-02-22       Impact factor: 4.050

6.  Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections.

Authors:  Cecilia Gómez-Calderón; Carol Mesa-Castro; Sara Robledo; Sergio Gómez; Santiago Bolivar-Avila; Fredyc Diaz-Castillo; Marlen Martínez-Gutierrez
Journal:  BMC Complement Altern Med       Date:  2017-01-18       Impact factor: 3.659

7.  Antiviral Strategies Against Chikungunya Virus.

Authors:  Rana Abdelnabi; Johan Neyts; Leen Delang
Journal:  Methods Mol Biol       Date:  2016

Review 8.  Antivirals against Chikungunya Virus: Is the Solution in Nature?

Authors:  Daniel Oliveira Silva Martins; Igor de Andrade Santos; Débora Moraes de Oliveira; Victória Riquena Grosche; Ana Carolina Gomes Jardim
Journal:  Viruses       Date:  2020-02-29       Impact factor: 5.048

Review 9.  Small Molecule Inhibitors Targeting Chikungunya Virus.

Authors:  Nicole Haese; John Powers; Daniel N Streblow
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 10.  Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.

Authors:  Simon-Djamel Thiberville; Nanikaly Moyen; Laurence Dupuis-Maguiraga; Antoine Nougairede; Ernest A Gould; Pierre Roques; Xavier de Lamballerie
Journal:  Antiviral Res       Date:  2013-06-28       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.